SCHEMBL17188780

SCHEMBL17188780

C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1CCCN1C(=O)[C@@H](Nc1nc(-c2sc3ccccc3c2C)cs1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17188712 0.89 — —
SCHEMBL17188751 0.87 — —
SCHEMBL17188776 0.85 — —
SCHEMBL17188764 0.85 — —
SCHEMBL17188788 0.85 — —
SCHEMBL17188727 0.84 — —
SCHEMBL17188762 0.83 — —
SCHEMBL17188741 0.83 — —
SCHEMBL17188718 0.82 — —
SCHEMBL17188729 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2265606-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2015-10-21 — — EP disclosed
US-8993128-B2 Heterocyclic compound and organic light-emitting device containing same SAMSUNG DISPLAY CO., LTD. (KR) 2015-03-31 — — US disclosed
Send feedback